Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Roivant Sciences Ltd. | Director | Common Shares | 1.28M | $15M | $11.77 | Sep 25, 2024 | Direct |
Arbutus Biopharma Corp | Director | Common Shares | 46.1K | $170K | $3.69 | Aug 14, 2024 | Direct |
Roivant Sciences Ltd. | Director | Stock Option (Right to Buy) | 27.9K | Sep 10, 2024 | Direct | ||
Arbutus Biopharma Corp | Director | Stock Option (Right to Buy) | 0 | Aug 14, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ROIV | Roivant Sciences Ltd. | Sep 24, 2024 | 2 | -$5.87M | 4 | Sep 26, 2024 | Director |
ROIV | Roivant Sciences Ltd. | Sep 10, 2024 | 2 | $0 | 4 | Sep 12, 2024 | Director |
ABUS | Arbutus Biopharma Corp | Aug 14, 2024 | 3 | -$1.88K | 4 | Aug 16, 2024 | Director |
ABUS | Arbutus Biopharma Corp | May 23, 2024 | 1 | $0 | 4 | May 24, 2024 | Director |
ROIV | Roivant Sciences Ltd. | Mar 7, 2024 | 4 | $0 | 4 | Mar 7, 2024 | Director |
ROIV | Roivant Sciences Ltd. | Sep 28, 2023 | 4 | -$79.7M | 4 | Oct 2, 2023 | Director |
ROIV | Roivant Sciences Ltd. | Sep 12, 2023 | 2 | $0 | 4 | Sep 14, 2023 | Director |
ABUS | Arbutus Biopharma Corp | May 24, 2023 | 1 | $0 | 4 | May 26, 2023 | Director |
ROIV | Roivant Sciences Ltd. | Nov 9, 2022 | 5 | -$18.6M | 4 | Nov 14, 2022 | Director |
ROIV | Roivant Sciences Ltd. | Sep 15, 2022 | 2 | $0 | 4 | Sep 19, 2022 | Director |
ABUS | Arbutus Biopharma Corp | May 25, 2022 | 1 | $0 | 4 | May 26, 2022 | Director |
ROIV | Roivant Sciences Ltd. | Oct 1, 2021 | 0 | $0 | 3 | Oct 1, 2021 | Director |
ABUS | Arbutus Biopharma Corp | Jun 3, 2021 | 1 | $0 | 4 | Jun 7, 2021 | Director |